Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease

Brain Research

Volumn 1214, Issue , 2008, Pages 169-176

  Oyagi, A ^a   Oida, Y ^a   Hara, H ^a,a   Izuta, H ^a   Shimazawa, M ^a   Matsunaga, N ^a   Adachi, T ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

6 OHDA; Antioxidant; MPTP; Parkinson disease; SUN N8075

Indexed keywords

1 (4 AMINO 2,3,5 TRIMETHYLPHENOXY) 3 [4 [4 (4 FLUOROBENZYL)PHENYL] 1 PIPERAZINYL] 2 PROPANOL DIMETHANESULFONATE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; HYDROGEN PEROXIDE; OXIDOPAMINE; REACTIVE OXYGEN METABOLITE; SUN N 8075;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; LIPID PEROXIDATION; MALE; MOUSE; NEUROBLASTOMA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

MUS;

EID: 44249115522     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.02.073     Document Type: Article

References (26)

1. Ali S.F. David S.N. Newport G.D. Cadet J.L. Slikker W. Jr. MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels Synapse 18 1994 27 34
2. Annoura H. Nakanishi K. Toba T. Takemoto N. Imajo S. Miyajima A. Tamura-Horikawa Y. Tamura S. Discovery of (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-[4-[4-(4-fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity J. Med. Chem. 43 2000 3372 3376
3. Araki T. Kumagai T. Tanaka K. Matsubara M. Kato H. Itoyama Y. Imai Y. Neuroprotective effect of riluzole in MPTP-treated mice Brain Res. 918 2001 176 181
4. Burns R.S. Chiueh C.C. Markey S.P. Ebert M.H. Jacobowitz D.M. Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Proc. Natl. Acad. Sci. U. S. A. 80 1983 4546 4550
5. Gassen M. Gross A. Youdim M.B. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine Mov. Disord. 13 1998 242 248
6. Glinka Y. Gassen M. Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity J. Neural Transm. Suppl. 50 1997 55 66
7. Grims J.D. Hassan M.N. Thakar J.H. Prevention of progression of Parkinson's disease with antioxidative therapy Prog. Neuropsychopharmacol. Biol. Psychiatry 12 1988 165 172
8. Hantraye P. Brouillet E. Ferrante R. Palfi S. Dolan R. Matthews R.T. Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced Parkinsonism in baboons Nat. Med. 2 1996 1017 1021
9. Hara H. Kogure K. Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative) J. Pharmacol. Exp. Ther. 255 1990 906 913
10. Hara H. Ohta M. Ohta K. Kuno S. Adachi T. Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells Redox Rep. 8 2003 193 197
11. Heikkila R.E. Manzino L. Cabbat F.S. Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors Nature 311 1984 467 469
12. Johannessen J.N. Sobotka T.J. Weise V.K. Markey S.P. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4ô-amino-MPTP are linked to the persistence of pyridinium metabolites J. Neurochem. 57 1991 981 990
13. Kasai H. Nishimura S. Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents Environ. Health Perspect. 67 1986 111 116
14. Kawasaki T. Ishihara K. Ago Y. Baba A. Matsuda T. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum J. Pharmacol. Exp. Ther. 322 2007 274 281
15. Kotani Y. Morimoto N. Oida Y. Tamura Y. Tamura S. Inoue T. Shimazawa M. Yoshimura S. Iwama T. Hara H. Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075), a novel neuroprotective agent with antioxidant properties Neuroscience 149 2007 779 788
16. Nicklas W.J. Vyas I. Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sci. 36 1985 2503 2508
17. Oida Y. Kitaichi K. Nakayama H. Ito Y. Fujimoto Y. Shimazawa M. Nagai H. Hara H. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain Brain Res. 1082 2006 196 204
18. Przedborski S. Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease Antioxid. Redox Signal. 7 2005 685 693
19. Ricaurte G.A. Langston J.W. Delanney L.E. Irwin I. Peroutka S.J. Forno L.S. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment Brain Res. 376 1986 117 124
20. Robins P. Japanese Pharmacological Society—77th Annual Meeting. Part II. 8–10 March 2004, Osaka, Japan. I. Drugs 7 2004 298 300
21. Sankar S.R. Manivasagam T. Krishnamurti A. Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables Cell. Mol. Biol. Lett. 12 2007 473 481
22. Sato S. Mizuno Y. Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease Neurology 64 2005 1081 1083
23. Schneider J.S. Markham C.H. Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry Brain Res. 373 1986 258 267
24. Soto-Otero R. Mendez-Alvarez E. Hermida-Ameijeiras A. Munoz-Patino A.M. Labandeira-Garcia J.L. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease J. Neurochem. 74 2000 1605 1612
25. Turski L. Bressler K. Rettig K.J. Loschmann P.A. Wachtel H. Protection of substantia nigra from MPP+ neurotoxicity by N -methyl- d -aspartate antagonists Nature 349 1991 414 418
26. Watanabe H. Muramatsu Y. Kurosaki R. Michimata M. Matsubara M. Imai Y. Araki T. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study Eur. Neuropsychopharmacol. 14 2004 93 104